SNDX filings
Corporate insider profile
Keith A. Goldan Filing Activity
Latest reported as Chief Financial Officer of Syndax Pharmaceuticals Inc (SNDX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$22,351.23
- Latest transaction
- Jun 1, 2026
Affiliated corporations
Reported company relationships
Transaction history
